The DOI matches its Crossref record.
Allopurinol in the Treatment of Gout
Abstract
ALLOPURINOL, 4-hydroxypyrazolo (3,4-d) k pyrimidine (4-HPP), * recently intro-duced as a new type of agent useful in the treatment of gout, developed from studies undertaken to increase the therapeutic efficacy of 6-mercaptopurine (6-MP) and related thiopurines in leukemia. Since the biologically active form of 6-MP is its ribonucleotide (Figure 1) (1-4), all reac-tions leading to the removal of 6-MP from this anabolic pathway would decrease its activity. Studies on the metabolic fate of 6-MP in the mouse (5) and the human (6-9) have shown that the major catabolic pathway is oxidative. About 25 to 30% of the total dose of 6-MP is converted to the inert metabolite, 6-thiouric acid, which is excreted in the urine (6-10). A con-siderable amount of desulfuration, with the resultant formation of sulfate, also occurs. The enzyme responsible for the oxida-tion of 6-MP to 6-thiouric acid is xanthine oxidase (5, 10, 11) the same enzyme that converts the normal purines, hypoxanthine and xanthine, to uric acid (Figure 2). It seemed possible that an inhibitor of xan-thine oxidase might be a useful adjuvant in 6-MP therapy. From the wide variety of purines and purine analogues that act as xanthine oxidase inhibitors in vitro, Elion and associates (8, 12) chose 4-HPP for study in vivo. This compound is an isomer of hypoxanthine in which the car-bon and nitrogen atoms in the 7 and 8 positions of the purine ring are inter-changed (Figure 3). Although several other pyrazolopyrimidines are active as xanthine Received August 5, 1965; accepted for publica-
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Zhang, W., Doherty, M., Bardin, T., Pascual, E., Barskova, V, Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055269 · Cited by 1,407
The purine path to chemotherapy
Elion, G. B. (1989) · Science · doi:10.1126/science.2649979 · Cited by 687
Schumacher, H. R., Becker, M. A., Wortmann, R. L., MacDonald, P. A., Hunt, B., Streit, J., Lademacher, C., & Joseph‐Ridge, N. (2008) · Arthritis Care & Research · doi:10.1002/art.24209 · Cited by 638
Jordan, K. M., Cameron, J. S., Snaith, M., Zhang, W., Doherty, M., Seckl, J., Hingorani, A., Jaques, R., & Nuki, G. (2007) · Rheumatology · doi:10.1093/rheumatology/kem056a · Cited by 552
Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency in Gout
KELLEY, W. N., GREENE, M. L., ROSENBLOOM, F. M., HENDERSON, J. F., & SEEGMILLER, J. E. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-1-155 · Cited by 446
Metadata
- Authors
- RUNDLES, R. W., METZ, E. N., & SILBERMAN, H. R.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1966-02-01
- Volume
- 64
- Issue
- 2
- Pages
- 229-258
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1494441064
- Cited by
- 241
- References
- 0
- FWCI
- 23.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Allopurinol in the Treatment of Gout. https://app.cochat.ai/papers/10.7326/0003-4819-64-2-229
- The paper
- RUNDLES, R. W., METZ, E. N., & SILBERMAN, H. R. (1966). Allopurinol in the Treatment of Gout. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-64-2-229
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.